IM Cannabis Corp. (IMCC) vs Lakewood-Amedex Biotherapeutics, Inc. (LABT)

A side-by-side comparison of IM Cannabis Corp. and Lakewood-Amedex Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
IM Cannabis Corp. logo
IMCC
IM Cannabis Corp.
$1M
$2.00HealthcareDelayed quote: Oct 6, 2026, 10:27 AM EDT
Lakewood-Amedex Biotherapeutics, Inc. logo
LABT
Lakewood-Amedex Biotherapeutics, Inc.
$1M
$0.83HealthcareDelayed quote: Oct 6, 2026, 10:29 AM EDT

Total return — IMCC vs LABT

growth of $100 · dividends reinvested · last 1y
IMCC -78.4% (-78.4%/yr)LABT -99.0% (-99.0%/yr)IMCC compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100$22$1
IMCC LABT

IMCC vs LABT: by the numbers

  • •LABT is the larger company ($1M vs $1M market cap).
  • •Both run net losses; LABT's is the smaller (0.00% vs -38.08% net margin).

Metrics side by side

Valuation

MetricIMCCLABT
P/S ratio0.04N/A
P/B ratioN/A0.34

Profitability

MetricIMCCLABT
Gross margin13.74%0.00%
Operating margin-25.95%0.00%
Net margin-38.08%0.00%
ROEN/A-169.64%
ROIC-128.95%-163.98%

Growth (annualized)

MetricIMCCLABT
Revenue CAGR (5Y)4.19%N/A
Total return CAGR (5Y)-80.08%N/A

Go deeper

Full IMCC analysisFull LABT analysisInteractive comparison tool

Dig into the metrics

IM Cannabis ROELakewood-Amedex Biotherapeutics ROEIM Cannabis operating marginLakewood-Amedex Biotherapeutics operating marginIM Cannabis revenue growthLakewood-Amedex Biotherapeutics revenue growthIM Cannabis free cash flowLakewood-Amedex Biotherapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.